ARRAY BIOPHARMA INC 4
4 · ARRAY BIOPHARMA INC · Filed Jul 15, 2010
Insider Transaction Report
Form 4
SNITMAN DAVID
DirectorCOO and VP, Business Devel.
Transactions
- Exercise/Conversion
Common Stock
2010-06-29$0.60/sh+33,789$20,273→ 950,184 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-06-29−33,789→ 0 totalExercise: $0.60From: 2009-11-13Exp: 2010-07-01→ Common Stock (33,789 underlying)
Holdings
- 456,473(indirect: By Grat)
Common Stock
- 119,950(indirect: By Trust)
Common Stock